LIMPII/SR-B2 Antibody (017) [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90381C
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Mouse
Applications
ELISA
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 017
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for LIMPII/SR-B2 Antibody (017) [DyLight 650]
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Mouse LIMPII/SR-B2 (Met 1-Thr 432; Accession#: NP_031670.1).
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for LIMPII/SR-B2 Antibody (017) [DyLight 650]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LIMPII/SR-B2
Long Name
Lysosomal Integral Membrane Protein II
Alternate Names
CD36L2, LPG85, SCARB2, SR-B2, SR-BII, SRB2
Gene Symbol
SCARB2
Additional LIMPII/SR-B2 Products
Product Documents for LIMPII/SR-B2 Antibody (017) [DyLight 650]
Product Specific Notices for LIMPII/SR-B2 Antibody (017) [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...